Ogilvy CommonHealth Asia Pac. Hires Dr Robert Liversage

Ogilvy CommonHealth Asia Pacific (OCHAP) announced today that they have appointed Dr Robert Liversage as their Director of Scientific & Editorial Services in their Australia office.  The newly created role will see Dr Liversage take responsibility for content development, scientific council and medical advice across all areas of the business from prescription medications to OTC and pharmacy brands, and from medical education to disease awareness programmes. 

Robert has a Neuroscience and Neuropharmacology PhD from the University of Leeds (UK) and spent several years in high-science, medical writing roles in the UK before relocating to Australia.  Since 2008 he has been working within the editorial departments of Australian medical communications businesses and healthcare advertising agencies writing within the pharmaceutical space, leading the editorial and medical elements across both promotional and education programmes. He has a plethora of experience across disease areas spanning Oncology, Mental Health, Diabetes, Respiratory, CV, Dermatology, medical devices and Infectious Diseases.

Gary Pattison, Ogilvy CommonHealth Group Managing Director in Australia said “I am thrilled that Rob will be joining our growing, expert team at Ogilvy.  He has a solid track record and a reputation as one of the best in the business.”

Pattison went on to say, “At OCHAP we have spent the last 6-8 months looking carefully at our business, our structure and how we add value to our clients brands in this ever-changing world of health and wellness.  We live and breath change here – we never stand still.  We must offer excellence in client service and creative ideation of course – but none of this matters if you get the science wrong.  Rob is a key hire in this respect as we plan for the future of the business and the future of our clients business.”

Rohit Sahgal, Director for Ogilvy CommonHealth Asia Pacific commented “Staying one step ahead is a tradition at Ogilvy, and doing that in the area of scientific innovation has been a key part of a multi-faceted specialist strategy. Rob's appointment reinforces our commitment to providing cutting edge solutions and building enduring client partnerships."